← All Sponsors
SPONSOR

Urovant Sciences GmbH

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Neurogenic Detrusor Overactivity
NCT05491525 Phase 2, Phase 3
Recruiting

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Neurogenic Detrusor Overactivity
United States View Trial →